Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 2, 2007

Cegedim to Pick Up Dendrite for $751M

  • Cegedim, French maker of software for the life sciences industry, will spend $751 million for Dendrite International to expand the reach of its services into the U.S. and Asia-Pacific region.

    The offering of $16 per share represents a 25% premium over Dendrite’s closing price the day before the proposal. Dendrite opened trading at $15.61.

    Cegedim expects the combined company to have estimated pro forma annual revenues of $1.1 billion and operate in more than 75 countries across Europe, the Americas, and Asia-Pacific.

    "We are very excited to join forces with Dendrite's talented team to create a truly global business with increased international reach, a broader scope of product offerings, and the strength to invest in the development of innovative technologies," remarks Jean-Claude Labrune, founder, chairman, and CEO of Cegedim.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »